The role of nocturia in the quality of life of men with lower urinary tract symptoms

BJU International

Volumn 105, Issue 8, 2010, Pages 1141-1146

  Van Dijk, Marleen M ^a   Wijkstra, Hessel ^a   Debruyne, Frans M ^b   De La Rosette, Jean J M C H ^a   Michel, Martin C ^a  

^a UNIVERSITY OF AMSTERDAM   (Netherlands)

^b RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

1 adrenoceptor antagonist; BPH; Nocturia; Quality of life; Transurethral microwave thermotherapy; TURP

Indexed keywords

ALFUZOSIN; ALPHA ADRENERGIC RECEPTOR BLOCKING AGENT; TAMSULOSIN; TERAZOSIN;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; HUMAN; INTERMETHOD COMPARISON; INTERNATIONAL PROSTATE SYMPTOM SCORE; LOWER URINARY TRACT SYMPTOM; MAJOR CLINICAL STUDY; MALE; NOCTURIA; PRIORITY JOURNAL; PROSTATE HYPERTROPHY; QUALITY OF LIFE; RETROSPECTIVE STUDY; RISK REDUCTION; TRANSURETHRAL MICROWAVE THERMOTHERAPY; TRANSURETHRAL RESECTION; TREATMENT RESPONSE; URINARY URGENCY; URINE FLOW RATE; WATCHFUL WAITING;

ADRENERGIC ALPHA-1 RECEPTOR ANTAGONISTS; AGED; HUMANS; LOWER URINARY TRACT SYMPTOMS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; NOCTURIA; PROSTATIC HYPERPLASIA; QUALITY OF LIFE; RETROSPECTIVE STUDIES; TRANSURETHRAL RESECTION OF PROSTATE; WATCHFUL WAITING;

EID: 77950200671     PISSN: 14644096     EISSN: 1464410X     Source Type: Journal    
DOI: 10.1111/j.1464-410X.2009.08969.x     Document Type: Article

References (32)

1. van Kerrebroeck P, Abrams P, Chaikin D et al. The standardisation of terminology in nocturia: report from the standardisation sub-committee of the International Continence Society. Neurourol Urodyn 2002 21 : 179 183
2. Abrams P. Nocturia: the major problem in patients with lower urinary tract symptoms suggestive of benign prostatic obstruction (LUTS/BPO). Eur Urol Suppl 2005 3 : 8 16
3. Irwin DE, Milsom I, Hunskaar S et al. Population-based survey of urinary incontinence, overactive bladder, and other lower urinary tract symptoms in five countries: results of the EPIC study. Eur Urol 2006 50 : 1306 1315
4. Schneider T, de la Rosette JJMCH, Michel MC. Nocturia - a non-specific but important symptom of urological disease. Int J Urol 2009 16 : 249 256
5. Homma Y, Yamaguchi T, Kondo Y et al. Significance of nocturia in the International Prostate Symptom Score for benign prostatic hyperplasia. J Urol 2002 167 : 172 176
6. Johnson TM, Jones K, Williford WO et al. Changes in nocturia from medical treatment of benign prostatic hyperplasia: secondary analysis of the Department of Veterans Affairs Cooperative Study trial. J Urol 2003 170 : 145 148
7. Cai T, Gardener N, Abraham L et al. Impact of surgical treatment on nocturia in men with benign prostatic obstruction. BJU Int 2006 98 : 799 805
8. Seki N, Yunoki T, Tomoda T et al. Association among the symptoms, quality of life and urodynamic parameters in patients with improved lower urinary tract symptoms following a transurethral resection of the prostate. Neurourol Urodyn 2008 27 : 222 225
9. Ushijima S, Ukimura O, Okihara K et al. Visual analog scale questionnaire to assess the quality of life specific to each symptom of the International Prostate Symptom Score. J Urol 2006 176 : 665 671
10. Batista-Miranda JE, Molinuevo B, Pardo Y. Impact of lower urinary tract symptoms on quality of life using functional assessment cancer therapy scale. Urology 2007 69 : 285 288
11. Jardin A, Bensadoun H, Delauche-Cavallier MC, Attali P, The BPH-ALF Group. Alfuzosin for treatment of benign prostatic hypertrophy. Lancet 1991 337 : 1457 1461
12. Roehrborn C, van Kerrebroeck P, Nordling J. Safety and efficacy of alfuzosin 10 mg once-daily in the treatment of lower urinary tract symptoms and clinical benign prostatic hyperplasia: a pooled analysis of three double-blind, placebo-controlled studies. BJU Int 2003 92 : 257 261
13. Chapple CR, Carter P, Christmas TJ et al. A three month double-blind study of doxazosin as treatment for benign prostatic bladder outlet obstruction. Br J Urol 1994 74 : 50 6
14. Johnson TMII, Burrows PK, Kusek JW et al. The effect of doxazosin, finasteride and combination therapy on nocturia in men with benign prostatic hyperplasia. J Urol 2007 178 : 2045 2051
15. 1c-adrenoceptor antagonist: a randomized, controlled trial in patients with benign prostatic 'obstruction' (symptomatic BPH). Br J Urol 1995 76 : 325 336
16. Debruyne FMJ, Witjes WPJ, Fitzpatrick J et al. The international terazosin trial: a multicentre study of the long-term efficacy and safety of terazosin in the treatment of benign prostatic hyperplasia. Eur Urol 1996 30 : 369 376
17. Kirby RS, Coppinger MO, Chapple CR, Flannigan M, Milrov EJ. Prazosin in the treatment of prostatic obstruction. A placebo-controlled study. Br J Urol 1987 60 : 136 142
18. Kawabe K, Ueno A, Takimoto Y et al. Use of an α1-blocker, YM 617, in the treatment of benign prostatic hypertrophy. J Urol 1990 144 : 908 912
19. 1A-adrenoceptor antagonist. A meta-analysis of two randomized, placebo-controlled multicentre studies in patients with benign prostatic obstruction (symptomatic BPH). Eur Urol 1996 29 : 155 167
20. Djavan B, Milani S, Davies J, Bolodeoku J. The impact of tamsulosin oral controlled absorption system (OCAS) on nocturia and the quality of sleep: preliminary results of a pilot study. Eur Urol Suppl 2005 4 : 61 8
21. Kaplan SA, Roehrborn CG, Rovner ES et al. Tolterodine and tamsulosin for treatment of men with lower urinary tract symptoms and overactive bladder. A randomized controlled trial. J Am Med Assoc 2006 296 : 2319 2328
22. Blute ML, Tomera KM, Hellerstein DK et al. Transurethral microwave thermotherapy for management of benign prostatic hyperplasia: results of the United States Prostatron Cooperative Study. J Urol 1993 150 : 1591 1596
23. Bdesha AS, Bunce CJ, Kelleher JP et al. Transurethral microwave treatment for benign prostatic hypertrophy: a randomised controlled clinical trial. Br Med J 1993 306 : 1293 1296
24. de la Rosette JJMCH, Laguna MP, Gravas S, de Wildt MJAM. Transurethral microwave thermotherapy: the gold standard for minimally invasive therapies for patients with benign prostatic hyperplasia? J Endourol 2003 17 : 245 251
25. Bosch JLHR, Hop WC, Kirkels WJ, Schröder FH. The International Prostate Symptom Score in a community-based sample of men between 55 and 74 years of age: prevalence and correlation of symptoms with age, prostate volume, flow rate and residual volume. Br J Urol 1995 75 : 622 630
26. Paick J-S, Ku JH, Shin JW, Yang JH, Kim SW. α-Blocker monotherapy in the treatment of nocturia in men with lower urinary tract symptoms: a prospective study of response prediction. BJU Int 2006 97 : 1017 1023
27. Bing MH, Moller LA, Jennum P, Mortensen S, Lose G. Validity and reliability of a questionnaire for evaluating nocturia, nocturnal enuresis and sleep-interruptions in an elderly population. Eur Urol 2006 49 : 710 719
28. Wagg A, Andersson K-E, Cardozo L et al. Nocturia: morbidity and management in adults. Int J Clin Pract 2005 59 : 938 945
29. Paick J-S, Kim SW, Oh S-J, Ku JH. Voiding patterns in men and women with lower urinary tract symptoms combined with nocturia. Int J Urol 2007 14 : 699 703
30. Ezz El Din K, Kiemeney LALM, de Wildt MJAM et al. The correlation between bladder outlet obstruction and lower urinary tract symptoms as measured by the international prostate symptom score. J Urol 1996 156 : 1020 1025
31. Taylor J, Harrison SCW, Assassa RP, McGrother CW. The pattern and progression of lower urinary tract symptoms after transurethral prostatectomy compared with those seen in the general population. Eur Urol 2007 51 : 1023 1030
32. Michel MC, Mehlburger L, Schumacher H, Bressel H-U, Goepel M. Effect of diabetes on lower urinary tract symptoms in patients with benign prostatic hyperplasia. J Urol 2000 163 : 1725 1729